KDOQI (Kidney Disease Outcomes Quality Initiative)


NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI |

KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients


Tables
Figures
Acronyms and abbreviations
Work group members
KDOQI advisory board members
Foreword
Overview of epidemiology of cardiovascular disease
Overview of epidemiology of cardiovascular disease in children

Section I. Guidelines on evaluation and management of cardiovascular diseases

Section II. Guidelines on management of cardiovascular risk factors

Section III. State of the science: novel and controversial topics in cardiovascular diseases

Intradialytic Hypotension
Biomarkers
Troponin
Inflammation
Oxidative Stress
Nutritional and Metabolic Factors
Body Weight and Management
Omega-3 Fatty Acids
Homocysteine
Lipoprotein(a) and Apolipoprotein(a) Polymorphism
Malnutrition
Risk Stratification
Overview of Risk Stratification
Family History and Genetics
Menopause
Preventive Foot Care in Diabetes
Aspirin

Methods for review of article
Work group biographies
Acknowledgment
References
Disclaimer